Q2N0S7 (Q2N0S7_9HIV1) Human immunodeficiency virus 1
Envelope glycoprotein gp160 UniProtKBInterProInteractive Modelling
860 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
24 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Cryo-EM structure at 3.6 A resolution of vaccine-elicited antibody vFP16.02 in complex with HIV-1 E… |
Heteromer Q2N0S5; | 9×NAG; 12×NAG; 15×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 6×NAG; | ||||
| Assess | ||||||
| Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP |
Heteromer Q2N0S6; | 9×NAG; 6×NAG; 24×NAG; 3×NAG; 21×NAG; | ||||
| Assess | ||||||
| Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP |
Heteromer Q2N0S6; | 3×NAG; 36×NAG; 3×NAG; 3×NAG; 15×NAG; | ||||
| Assess | ||||||
| Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP |
Heteromer Q2N0S6; | 4×NAG; 36×NAG; 1×NAG; 2×NAG; 12×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibo… |
Heteromer Q2N0S6; | 27×NAG; 3×NAG; 9×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of HIV-1 Env(CH848 10.17 DS.SOSIP_DT) in complex with DH1030.1 Fab |
Heteromer A0A1W6IPB2; | 9×NAG; 3×NAG; 3×NAG; 1×NAG; 18×NAG; | ||||
| Assess | ||||||
| HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody F… |
Heteromer Q2N0S6; | 22×NAG; 1×NAG; 2×NAG; 1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 22×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elic… |
Heteromer Q2N0S6; | 21×NAG; 9×NAG; 3×NAG; 6×NAG; 3×NAG; 12×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 1… |
Heteromer A0A1W6IPB2; | 12×NAG; 3×NAG; 24×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicite… |
Heteromer Q2N0S6; | 8×NAG; 12×NAG; 7×NAG; 12×NAG; 3×NAG; 9×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure at 3.8 A resolution of vaccine-elicited antibody vFP20.01 in complex with HIV-1 E… |
Heteromer Q2N0S5; | 18×NAG; 12×NAG; 6×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; 3×MAN; | ||||
| Assess | ||||||
| Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 En… |
Heteromer Q2N0S6; | 21×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env |
Heteromer A0A1W6IPB2; | 9×NAG; 3×NAG; 3×NAG; 6×NAG; 27×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 … |
Heteromer Q2N0S6; | 21×NAG; 9×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env |
Heteromer A0A1W6IPB2; | 6×NAG; 6×NAG; 3×NAG; 18×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment |
Heteromer Q2N0S6; | 18×NAG; 21×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; | ||||
| Assess | ||||||
| VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure |
Heteromer P0DOX5; Q2N0S6; Q6N089; Q6P5S8; Q8N5F4; | 27×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
| Assess | ||||||
| Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664 |
Heteromer A0A6H1VCM1; | 18×NAG; 21×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; 3×MAN; | ||||
| Assess | ||||||
| HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 |
Heteromer A0A1Y1B8B1; P01840; Q2N0S6; | 3×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibo… |
Heteromer Q2N0S6; | 21×NAG; 3×NAG; 6×NAG; 3×NAG; 12×NAG; | ||||
| Assess | ||||||
| Glutaraldehyde-treated BG505 SOSIP.664 Env in complex with PGV04 Fab |
Heteromer Q2N0S5; | 6×NAG; 27×NAG; 3×NAG; 18×NAG; | ||||
| Assess | ||||||
| BG505 SOSIP in complex with sCD4, 17b, 8ANC195 |
Heteromer P01730; Q2N0S5; | 6×NAG; 3×NAG; 6×NAG; 18×NAG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Clade A BG505 Fusion Peptide (residue 512-520) in Complex with Broadly N… |
Heteromer | |||||
| Assess | ||||||
| Vaccine-elicited mouse FP-targeting neutralizing antibody vFP16.02 with F60P mutation on light chai… |
Heteromer | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6myy.1.A | monomer | 0.69 | 78.50 | |||
| Assess | ||||||
| 6b0n.1.C | monomer | 0.67 | 98.57 | |||
| Assess | ||||||